Literature DB >> 12949804

Mistletoe for cancer? A systematic review of randomised clinical trials.

Eduard Ernst1, Katja Schmidt, Miriam Katharina Steuer-Vogt.   

Abstract

Mistletoe extracts are widely used in the treatment of cancer. The results of clinical trials are however highly inconsistent. We therefore conducted a systematic review of all randomised clinical trials of this unconventional therapy. Eight databases were searched to identify all studies that met our inclusion/exclusion criteria. Data were independently validated and extracted by 2 authors and checked by the 3rd according to predefined criteria. Statistical pooling was not possible because of the heterogeneity of the primary studies. Therefore a narrative systematic review was conducted. Ten trials could be included. Most of the studies had considerable weaknesses in terms of study design, reporting or both. Some of the weaker studies implied benefits of mistletoe extracts, particularly in terms of quality of life. None of the methodologically stronger trials exhibited efficacy in terms of quality of life, survival or other outcome measures. Rigorous trials of mistletoe extracts fail to demonstrate efficacy of this therapy. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949804     DOI: 10.1002/ijc.11386

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Anthroposophical medicine: a systematic review of randomised clinical trials.

Authors:  Edzard Ernst
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

2.  Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.

Authors:  A I Finall; S A McIntosh; W D Thompson
Journal:  BMJ       Date:  2006-12-23

3.  Mistletoe as a treatment for cancer.

Authors:  Edzard Ernst
Journal:  BMJ       Date:  2006-12-23

4.  Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review.

Authors:  Thomas Ostermann; Christa Raak; Arndt Büssing
Journal:  BMC Cancer       Date:  2009-12-18       Impact factor: 4.430

5.  [Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients].

Authors:  M K Steuer-Vogt; V Bonkowsky; M Scholz; C Fauser; K Licht; P Ambrosch
Journal:  HNO       Date:  2006-04       Impact factor: 1.284

Review 6.  Mistletoe therapy in oncology.

Authors:  M A Horneber; G Bueschel; R Huber; K Linde; M Rostock
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

7.  Suppressive effect of a standardized mistletoe extract on the expression of activatory NK receptors and function of human NK cells.

Authors:  Soo Jung Lee; Young-Ok Son; Hyunjin Kim; Joo-Young Kim; Soon-Won Park; Jae-Ho Bae; Hyung Hoi Kim; Eun-Yup Lee; Byung-Seon Chung; Sun-Hee Kim; Chi-Dug Kang
Journal:  J Clin Immunol       Date:  2007-05-25       Impact factor: 8.317

Review 8.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

9.  Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysis.

Authors:  Arndt Büssing; Christa Raak; Thomas Ostermann
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-14       Impact factor: 2.629

Review 10.  Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.

Authors:  Gunver S Kienle; Anja Glockmann; Michael Schink; Helmut Kiene
Journal:  J Exp Clin Cancer Res       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.